Loading...
•
Dec 31, 2022
Acadia Healthcare Q4 2022 Earnings Report
Acadia Healthcare's Q4 2022 financial results were announced, revealing a revenue increase and strategic growth investments.
Key Takeaways
Acadia Healthcare reported a revenue of $675.3 million for Q4 2022, a 13.8% increase compared to Q4 2021. Net income attributable to Acadia was $61.1 million, or $0.67 per diluted share, while adjusted income from continuing operations was $68.1 million, or $0.74 per diluted share.
Revenue totaled $675.3 million, up 13.8% year-over-year.
Same facility revenue increased 9.4% compared to the fourth quarter of 2021.
Net income attributable to Acadia totaled $61.1 million, or $0.67 per diluted share.
Adjusted income from continuing operations attributable to Acadia stockholders totaled $68.1 million, or $0.74 per diluted share.
Forward Guidance
Acadia provided financial guidance for 2023, projecting revenue between $2.82 to $2.88 billion and adjusted earnings per diluted share between $3.10 to $3.40. For the first quarter of 2023, the company expects revenue of $690 to $700 million and adjusted earnings per diluted share of $0.70 to $0.74.
Positive Outlook
- Revenue: $2.82 to $2.88 billion
- Adjusted EBITDA: $635 to $675 million
- Adjusted earnings per diluted share: $3.10 to $3.40
- Operating cash flows: $450 to $500 million
- First Quarter 2023 Revenue: $690 to $700 million
Challenges Ahead
- Interest expense: $80 to $85 million
- Tax rate: 25% to 26%
- Depreciation and amortization expense: $125 to $135 million
- Stock compensation expense: $30 to $35 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...